Cencora, Inc. (COR)
NYSE: COR · Real-Time Price · USD
323.60
+1.57 (0.49%)
At close: Aug 31, 2026, 4:00 PM EDT
325.00
+1.40 (0.43%)
After-hours: Aug 31, 2026, 7:30 PM EDT

Cencora Financials Overview

Millions USD. Fiscal year is Oct - Sep.

Revenue & Profits

Fiscal QuarterQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Revenue
84,75578,35685,93283,72980,66475,45481,48779,05074,24168,41472,25368,92266,94763,45762,84761,17460,06557,71959,62958,912
Revenue Growth
5.07%3.85%5.46%5.92%8.65%10.29%12.78%14.69%10.90%7.81%14.97%12.67%11.46%9.94%5.40%3.84%12.47%17.42%13.54%19.63%
Gross Profit
3,6023,5723,0602,9482,8982,8612,5352,4302,3592,5292,4212,1832,1462,2952,0961,9862,0152,2332,0602,048
Operating Income
1,1991,3441,004944.58969.58999.6783.49694.06700.6838.6752.79553.36565.29694.68633.19551.73630.91854.72714.32654.64
Net Income
763.521,641559.65-339.7687.4717.87488.63.38483.46420.78601.5350.57479.58435.4479.75294.74406.96548.01449.11437.7
Earnings Per Share
3.948.402.87-1.753.523.682.500.012.422.092.981.732.352.132.331.411.922.592.132.08
EPS Growth
11.93%128.26%14.80%-45.45%76.08%-16.11%-99.28%2.98%-1.88%27.90%22.89%22.40%-17.76%9.39%-32.34%37.14%23.33%17.68%-

Revenue by Segment

Fiscal QuarterQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Total US Healthcare Solutions
74,86168,76576,21275,78971,34366,81972,55571,67167,19261,29365,18461,92959,90056,69356,23754,78853,38950,94352,98052,348
International Alliance Healthcare
6,6016,5166,5316,3946,2305,7725,9995,9395,6425,7555,7265,6295,6995,5615,4615,2325,4935,6095,5575,449
Other Healthcare Solutions
1,0791,0491,0931,5511,023924.79959.71,4431,4101,3681,3451,3661,3491,2041,1511,1561,1841,1681,0931,117
Animal Health
1,5201,4361,471-1,4721,3631,380-------------
Other Non-Strategic Businesses
733.55619.78657.63-635.77593.38622.47-------------
Eliminations
-39.71-30.48-32.73-4.94-40.2-18.78-29.58-3.08-2.12-1.98-1.2-1.34-0.93-1.19-1.03-1.77-1.47-1.01-0.62-0.63
Revenue (Total)
84,75578,35685,93283,72980,66475,45481,48779,05074,24168,41472,25368,92266,94763,45762,84761,17460,06557,71959,62958,912

Cash & Debt

Fiscal QuarterQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Cash & Investments
2,8152,1761,7534,3562,2321,9783,2243,1333,3062,0692,8722,5921,3891,5391,6923,3883,0342,9613,1692,547
Total Debt
14,46315,0929,9059,33110,1479,7669,7335,6236,1316,6716,1775,8946,3526,2646,8946,7257,3577,7667,9897,805
Net Cash (Debt)
-11,648-12,916-8,152-4,975-7,915-7,787-6,509-2,490-2,825-4,602-3,305-3,302-4,962-4,725-5,202-3,337-4,323-4,806-4,820-5,258
Net Cash Growth
--------------------
Net Cash Per Share
-60.06-66.10-41.74-25.66-40.54-39.92-33.35-12.57-14.12-22.88-16.37-16.23-24.28-23.13-25.21-15.89-20.42-22.67-22.83-24.94

Cash Flow & CapEx

Fiscal QuarterQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Operating Cash Flow
2,6541,339-2,3053,133109.253,351-2,7191,0002,478-878.44885.161,827744.94629.51710.081,164408.62266.59863.411,010
Capital Expenditures
-226.04-165.62-119.38-249.81-183.22-129.06-105.89-182.32-117.88-112.75-74.22-175.5-104.28-102.85-75.73-173.59-113.39-129.65-79.69-164.81
Free Cash Flow
2,4281,173-2,4252,884-73.973,222-2,825818.062,360-991.2810.941,651640.65526.65634.35990.88295.23136.93783.72845.01
Free Cash Flow Growth
--63.59%-252.50%----50.46%268.33%-27.84%66.65%117.00%284.61%-19.06%17.26%-72.81%--6.44%-28.43%

Margins

Fiscal QuarterQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Gross Margin
4.25%4.56%3.56%3.52%3.59%3.79%3.11%3.07%3.18%3.70%3.35%3.17%3.21%3.62%3.33%3.25%3.36%3.87%3.45%3.48%
Operating Margin
1.42%1.72%1.17%1.13%1.20%1.32%0.96%0.88%0.94%1.23%1.04%0.80%0.84%1.09%1.01%0.90%1.05%1.48%1.20%1.11%
Pretax Margin
1.18%2.67%0.82%-0.22%1.11%1.23%0.76%0.16%0.85%0.68%1.08%0.65%0.91%0.81%0.94%0.63%0.79%1.26%1.00%0.94%
Profit Margin
0.90%2.10%0.65%-0.41%0.85%0.95%0.60%0.00%0.65%0.61%0.83%0.51%0.72%0.69%0.76%0.48%0.68%0.95%0.75%0.74%
FCF Margin
2.86%1.50%-2.82%3.44%-0.09%4.27%-3.47%1.03%3.18%-1.45%1.12%2.40%0.96%0.83%1.01%1.62%0.49%0.24%1.31%1.43%

Dividends

Fiscal QuarterQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Dividend Per Share
0.6000.6000.6000.5500.5500.5500.5500.5100.5100.5100.5100.4850.4850.4850.4850.4600.4600.4600.4600.440
Dividend Per Share Growth
9.09%9.09%9.09%7.84%7.84%7.84%7.84%5.16%5.16%5.16%5.16%5.44%5.44%5.44%5.44%4.54%4.54%4.54%4.54%4.76%
Dividend Yield
0.83%0.73%0.67%0.71%0.73%0.77%0.94%0.92%0.91%0.84%0.98%1.10%1.02%1.22%1.16%1.41%1.34%1.21%1.40%1.55%

Valuation

Fiscal QuarterQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
20.9823.9840.32-30.6331.8531.1029.2323.6826.1421.8920.7123.0420.0319.3616.5116.0918.7417.1416.12
Forward PE
15.2117.6119.1918.3618.1417.6615.0015.5316.0817.7815.9214.4615.8713.5714.4512.0112.6914.0912.4611.51
P/FCF Ratio
13.5639.22-18.89-15.08-14.7211.47-11.2610.4713.9413.2316.2812.7114.3811.3512.7211.14
PS Ratio
0.170.190.200.190.180.170.140.150.160.180.150.140.150.130.140.120.130.140.130.12